Table 6

- Summary of Rosai-Dorfman disease cases from 2 tertiary hospitals in the Western regions of Saudi Arabia.

VariableCoefficientSEt95%CIP-value
Age-0.270.12-0.22-0.28, 0.220.827
Gender-0.342.72-0.12-5.79,5.110.902
Education-7.676.68-1.15-21.04,5.700.256
Marital status-18.0912.35-1.46-42.82,6.630.148
Body mass index0.230.280.82-0.33,0.780.413
Hemoglobin A1c-1.241.61-0.77-4.46,1.980.444
Smoking12.9017.510.74-22.14,47.950.464
Physical inactivity-14.537.01-2.07-28.56, -0.500.043*
TIA-10.579.30-1.14-29.18,8.030.260
Retinopathy-3.3314.98-0.22-33.32,26.660.825
Financial satisfaction0.479.720.05-18.99,19.920.962
Ulcers-2.796.45-0.43-15.70,10.130.668
Urinary incontinence-4.343.61-1.20-11.56, 2.880.234
Adherence-4.185.32-0.79-14.82,6.470.435
Duration of DM2.080.424.931.24, 2.930.001*
Neuropathy disability score-6.101.38-4.44-8.86-3.350.001*
Neuropathy symptoms score-1.710.85-2.02-3.40, -0.010.048*
Dyslipidemia1.462.890.50-4.32,7.240.616
NCS13.095.242.52.32,23.860.019

HRQoL:health-realted qulaity of life, Ci: confidence interval, NCS: nerve conduction studies, DM: diabetes mellitus, DN: diabetic neuropathy, TIA: transient ischemic attack, SE: standard error